HMA - Heads of Medicines Agencies
  • RSS
  • Sitemap
  • Login (HMA-DMS)
  • Contact
  • About HMA
  • Human Medicines
  • Veterinary Medicines
  • You are here:
  • Home
  • >Veterinary Medicines
  • >CMDv
  • >Procedural guidance
  • >Post Marketing Procedures
  • CMDv
    • About CMDv
    • COVID-19
    • BREXIT
    • Procedural Contact Points
    • Procedural guidance
      • General Information on Applications
      • Validation of Applications
      • Applications for Marketing Authorisation
      • Post Marketing Procedures
        • Variations
        • Renewals
        • Pharmacovigilance
      • Referrals
      • ASMF
      • SPC, Labelling and Package leaflet
      • Miscellaneous
    • Questions & Answers
    • Publications
  • VMRI Product Index
  • National Contacts

 

Post Marketing Procedures

Best practice guide for changing the reference member state

Best practice guide for changing the reference member state track changes

Guidance for marketing authorisation transfer - National requirements (April 2021)

Guidance for post authorisation activities after partial marketing authorisation transfer - Partial MAH transfer

Guidance for administration of the Sunset Clause

 

Templates relevant for all procedure types

The Qualified Person's declaration template

Applicant's template for the post-authorisation commitments

 

Variations

Renewals

Pharmacovigilance

The United Kingdom (UK) withdrew from the European Union (EU) on 31 January 2020 and is no longer an EU Member State. HMA and CMDh/v are in the process of making appropriate changes to this website. If the site still contains content that does not yet reflect the withdrawal of the UK from the EU, this is unintentional and will be addressed. In case you notice information that should be updated, please report this website link using the contact form.

  • Useful Links
  • Privacy Policy
  • Credits & Disclaimer
  • Contact
© Heads of Medicines Agencies - https://www.hma.eu/577.html?&L=0